Edwards Lifesciences reported $937.8M in Trade Debtors for its fiscal quarter ending in September of 2026.





Trade Debtors Change Date
Abbott USD 11.22B 655M Mar/2026
Artivion USD 103.68M 6.31M Dec/2025
AtriCure USD 76.13M 3.85M Sep/2026
Baxter International USD 1.86B 158M Jun/2026
Becton, Dickinson and Co. USD 2.77B 407M Sep/2026
Boston Scientific USD 3.05B 22M Jun/2026
Cooper Companies USD 788.9M 20.3M Jun/2026
Dexcom USD 1.27B 175.4M Jun/2026
Edwards Lifesciences USD 937.8M 17.9M Sep/2026
Globus Medical USD 723.95M 15.33M Sep/2026
ICU Medical USD 206.26M 22.73M Sep/2026
Inogen USD 37.09M 4.11M Jun/2024
Insulet USD 689M 100.3M Sep/2026
Integra LifeSciences USD 248.99M 18.19M Sep/2026
Intuitive Surgical USD 1.72B 48.1M Sep/2026
J&J USD 19.05B 3.49B Jun/2026
Medtronic USD 6.36B 286M Jun/2026
Merit Medical Systems USD 250.9M 23.9M Jun/2026
Stryker USD 3.74B 172M Jun/2026
Tandem Diabetes Care USD 180.02M 17.96M Sep/2026
Teleflex USD 379.64M 15.03M Sep/2026
Zimmer Biomet Holdings USD 1.82B 46.5M Sep/2026